Gangnam Severance Hospital
Immunotherapy with Keytruda (Pembolizumab) in Republic of Korea typically costs from $5,200 to $8,500. The total expense depends on the number of cycles and specific cancer type. Patients save around 68% compared to the US, where this treatment costs $21,500 on average. Fees generally cover the medication, infusion administration, and initial specialist consultations in Seoul.
Bookimed Expert Insight: Choosing JCI-accredited centers like Severance Hospital provides access to world-class multidisciplinary oncology teams. This hospital serves over 1.6 million outpatients annually and maintains high global rankings. While individual sessions start around $3,200 at top centers, the long-term value lies in their advanced digital imaging and AI-driven treatment planning. These technologies help optimize dosage, potentially reducing unnecessary sessions and overall costs.
Why choose the Republic of Korea for immunotherapy with Keytruda (Pembrolizumab)?
Access advanced Immunotherapy with Keytruda (Pembolizumab) solutions in trusted clinics .
| Republic of Korea | Turkey | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | from $5,200 | from $3,300 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
Day 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
What patients like:
What patients don't like:
The doctor is a leading specialist in the treatment of breast cancer, with extensive training and experience. He completed his training and internship at Yonsei University Medical Center in South Korea and worked as a surgeon at the Yonsei Cancer Center.
From 2011 to 2013, he served as a consultant professor in the breast cancer department at Anderson University in the USA. His research focuses on the treatment of breast cancer using hormonal and chemotherapy drugs.
The doctor is a member of the Korean Medical Association, the American Society of Clinical Oncology, and the American Association for Cancer Research.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
Common side effects of Keytruda in Korea include dermatologic issues like rashes, endocrine disorders such as hypothyroidism, and gastrointestinal distress. Retrospective data from major Seoul centers indicates that pneumonitis and severe skin reactions like toxic epidermal necrolysis are critical risks requiring immediate monitoring.
Bookimed Expert Insight: While major centers like Severance Hospital serve millions, their specialization in multidisciplinary care is vital for immunotherapy. Analysis shows that Korean protocols emphasize early intervention for pneumonitis, as it remains the primary cause of severe complications in East Asian patients compared to Western datasets.
Patient Consensus: Patients report that fatigue and thyroid changes often emerge by the second cycle. Many advise tracking symptoms daily and avoiding spicy or fermented foods if gastrointestinal issues like diarrhea begin.
South Korea health insurance currently covers Keytruda for 118 indications across 13 cancer types. Key covered areas include lung cancer, melanoma, bladder cancer, Hodgkin lymphoma, and gastric cancer. Recent 2026 expansions added cervical, esophageal, biliary tract, and small intestine cancers to the national reimbursement framework.
Bookimed Expert Insight: While insurance significantly reduces costs, South Korean reimbursement logic is strictly biomarker-gated. Our data shows clinics like Severance Hospital use advanced digital imaging and EHRs to streamline these approvals. Patients with MSI-H solid tumors often secure coverage faster than those with site-specific indications. Always confirm your PD-L1 status before traveling to avoid unexpected out-of-pocket expenses.
Patient Consensus: Patients emphasize that biopsy-confirmed biomarkers are the only way to avoid high copays. While coverage lags behind the US, the 5% copayment for approved indications makes Korean oncology centers highly accessible.
Keytruda is approved for early-stage perioperative treatment in South Korea for non-small cell lung cancer, triple-negative breast cancer, and head and neck squamous cell carcinoma. The Ministry of Food and Drug Safety grants these approvals, though national insurance coverage often lags behind regulatory status for early-stage use.
Bookimed Expert Insight: While South Korean clinics like Severance Hospital hold Joint Commission International accreditation, a significant gap exists between drug approval and insurance reimbursement. International patients often access these early-stage treatments as non-reimbursed services, which costs $5,200 to $8,500 per cycle. This is still approximately 68% lower than the $21,500 average cost in the United States.
Patient Consensus: Patients report that while regulatory approval exists, accessing Keytruda for early-stage cancer requires navigating complex hospital-specific committees. Many recommend preparing international clinical trial data to support out-of-pocket treatment requests at major Seoul centers.
Keytruda is administered in South Korea as an intravenous infusion within specialized oncology units at JCI-accredited facilities. The typical 200mg dose takes 30 minutes, followed by 60 minutes of clinical monitoring. Protocol requires pre-infusion bloodwork and corticosteroids to prevent adverse reactions during the three-week cycle.
Bookimed Expert Insight: While major centers like Severance Hospital serve millions of patients, international departments offer a streamlined experience. You can often secure same-day consultations and infusions by using these dedicated wings. This bypasses the 2-hour wait times typically found in Korea's public cancer facilities.
Patient Consensus: Patients recommend bringing personal entertainment for the mandatory observation period. Many find the integration of supportive care, such as hydration protocols, helpful for managing fatigue.